Over the past two years, GLP-1s have transformed Carolina Martinez’s lifelong struggle to lose weight. She shed 80 pounds and ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...

Millions of Americans may be eligible to get blockbuster GLP-1 drugs like Wegovy and Zepbound for a much lower price starting July 1 under Medicare’s GLP-1 Bridge program.

Glucagon-like peptide-1 receptor agonists (GLP-1s) have become well known for their significant role as an aid in weight loss ...

Millions of people now take GLP-1 receptor agonist drugs such as semaglutide and tirzepatide for weight loss and diabetes ...

GLP-1 medications like Ozempic and Wegovy are changing the conversation around weight loss. And to be clear, they work. Clinical data shows users can lose significant body weight, often in the 10 to ...

NEW YORK — Health insurer Cigna will stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly 's Zepbound, in its employee health plan effective July 1, according to ...

Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...

GLP-1 medicines such as Ozempic and Mounjaro are not “magic injections” and can cause serious complications if used without ...